Starting a business in the pharmaceutical sector offers long-term growth and strong earning potential. With increasing demand for healthcare solutions, investing in medicine ursodeoxycholic acid can be a smart move. This bile acid treatment is widely recommended by doctors for liver-related issues.
If you are a wholesaler, doctor, or MR planning to enter the pharma sector, partnering with Ronish Bioceuticals can help you grow with a solid business foundation.
Ursodeoxycholic acid is a naturally occurring bile acid used to treat liver conditions such as primary biliary cholangitis, gallstones, and chronic liver diseases. This medicine works by reducing the amount of cholesterol produced by the liver and dissolving cholesterol in bile. It improves liver function and prevents damage to liver cells.
This compound is commonly available in the form of ursodeoxycholic acid tablets, cap ursodeoxycholic acid, suspensions, and syrups. Doctors widely prescribe it for both adults and children depending on the condition and requirement.
In today’s pharmaceutical market, generic ursodeoxycholic acid is gaining attention for being cost-effective and equally efficient.
Ronish Bioceuticals proudly offers Udnish 125, which is available in 125mg and 250mg suspension formats. This syrup is specially formulated for children and patients who are unable to swallow tablets or capsules.
Udnish 125 has been appreciated by healthcare professionals for its effective formulation and fast-acting results.
Each 5 ml of Udnish 125 – Ursodeoxycholic Acid 125/250mg Suspension as the active ingredient, helping in the treatment of liver disorders with minimal side effects. Its palatable taste and accurate composition make it a preferred choice in pediatric and geriatric treatment plans.
The demand for medicine ursodeoxycholic acid is growing due to an increase in liver-related conditions. As more patients get diagnosed with liver dysfunction, cholesterol gallstones, and hepatitis, the need for effective medication like tab ursodeoxycholic acid continues to rise.
Udnish 125 is backed by strong customer feedback and trust from healthcare professionals. Being part of Ronish Bioceuticals, this product carries quality assurance and is manufactured under WHO-GMP certified units. Our goal is to provide effective healthcare products with high standards of safety and reliability.
As a pharma partner, you will receive marketing support, promotional materials, and a profitable business model. Ronish Bioceuticals ensures all franchise partners receive full assistance including product training and customer service. You can count on timely product delivery and high-quality packaging.
Choosing a reliable partner is crucial for business success. Ronish Bioceuticals offers a well-established platform with various benefits:
We offer monopoly-based franchise rights to help you operate independently in your location. This gives you the freedom to grow without direct competition from our other partners.
Starting a pharma business with Ronish Bioceuticals doesn’t require a huge investment. Our flexible pricing and low MOQ (Minimum Order Quantity) allow you to start small and scale as you grow.
All our healthcare products are manufactured under GMP and WHO-compliant units. This ensures product safety, purity, and efficacy, giving you and your customers complete confidence.
You will receive MR bags, product cards, visual aids, promotional gifts, and samples to promote products effectively. We also help with product catalogues and doctor support materials.
We use trusted logistics partners for on-time delivery across India. Our packaging ensures product safety and long shelf life.
Starting your franchise is simple. Follow these steps:
The Indian pharma market is evolving, with more people choosing generic ursodeoxycholic acid due to its affordability. Government support and awareness programs have also improved trust in generics. This opens great business opportunities for those dealing with tab ursodeoxycholic acid or cap ursodeoxycholic acid.
Doctors and hospitals increasingly prescribe ursodeoxycholic acid for chronic liver treatment. This trend is especially strong in semi-urban and rural markets, making it a good choice for local distributors, medical representatives, and wholesalers.
If you are a pharma distributor or new business owner, third-party manufacturing service gives you a chance to build your brand with minimal setup cost. Ronish Bioceuticals provides end-to-end third-party manufacturing service, including product development, packaging, and quality control.
With this, you can focus on marketing and sales while we manage production and logistics. This also allows you to introduce your own label and build a business name in the ursodeoxycholic acid segment.
The pharmaceutical market continues to grow in India, and the demand for liver care medicines like ursodeoxycholic acid is consistent. Partnering with Ronish Bioceuticals for Udnish 125 can help you build a sustainable and profitable business. From quality products to full franchise support, we are committed to your success. Start your business today with a trusted name and grow your market presence.
If you’re planning to start a pharma business focused on ursodeoxycholic acid, connect with Ronish Bioceuticals and partner with a leading PCD Pharma Franchise Company in Haryana.
Ursodeoxycholic acid is used to treat liver diseases such as gallstones, primary biliary cholangitis, and chronic liver damage. It helps improve bile flow and reduces liver inflammation.
Yes, Udnish 125 is available in suspension form and is suitable for pediatric use under a doctor’s guidance.
Yes. Ronish Bioceuticals offers low investment options and full support to help you start and grow your pharma business.
It is available as ursodeoxycholic acid tablets, cap ursodeoxycholic acid, and oral suspension like Udnish 125.
Yes, we offer complete third-party manufacturing service for pharma companies and distributors looking to launch their own brand.